Drug Trial Radar · NCT06297226
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
230
Planned (sponsor's estimate)
Start
Mar 21, 2024
Primary completion
Jul 31, 2026
Study completion Jun 30, 2032
Sponsor
- Lead sponsor
- Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Mar 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory multiple myeloma.
Conditions
- Multiple Myeloma
Interventions
Arlocabtagene AutoleucelBiological
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1: Best overall response (BOR) of partial response (PR) or betterTime frame: Up to approximately 5 years
Locations
52 sites in 4 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Banner MD Anderson Cancer Center
Gilbert, Arizona · Recruiting
University of Arkansas for Medical Sciences
Little Rock, Arkansas · Recruiting
UCLA Hematology/Oncology - Westwood (Building 200 Suite 214)
Los Angeles, California · Recruiting
UCSF Helen Diller Medical Center at Parnassus Heights
San Francisco, California · Recruiting
Colorado Blood Cancer Institute
Denver, Colorado · Recruiting
Mayo Clinic in Florida
Jacksonville, Florida · Recruiting
Miami Cancer Institute at Baptist Health, Inc.
Miami, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
Winship Cancer Institute of Emory University
Atlanta, Georgia · Recruiting
Northside Hospital
Atlanta, Georgia · Recruiting
Northwestern Memorial Hospital
Chicago, Illinois · Recruiting
University of Chicago Medical Center
Chicago, Illinois · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
The University of Kansas Cancer Center - Westwood
Westwood, Kansas · Recruiting
Norton Women's and Children's Hospital
Louisville, Kentucky · Recruiting
Local Institution - 0065
Baltimore, Maryland · Withdrawn
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
Mayo Clinic in Rochester, Minnesota
Rochester, Minnesota · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey · Recruiting
Roswell Park Cancer Institute
Buffalo, New York · Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
University of North Carolina Medical Center
Chapel Hill, North Carolina · Recruiting
Local Institution - 0067
Charlotte, North Carolina · Withdrawn
Oncology Hematology Care
Cincinnati, Ohio · Recruiting
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
Oregon Health and Science University
Portland, Oregon · Recruiting
Sidney Kimmel Cancer Center - Jefferson Health
Philadelphia, Pennsylvania · Recruiting
Tennessee Oncology
Nashville, Tennessee · Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Recruiting
Local Institution - 0069
Austin, Texas · Withdrawn
UT Southwestern Medical Center
Dallas, Texas · Recruiting
University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Methodist HealthCare System of San Antonio Clinical Trials Office, Texas Transplant Institute
San Antonio, Texas · Recruiting
LDS Hospital
Salt Lake City, Utah · Recruiting
Virginia Oncology Associates
Norfolk, Virginia · Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.